Autophagy Maintenance (AUTOMAIN)
Phase 2 Recruiting
38 enrolled
Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery
Phase 1 Recruiting
25 enrolled
COAST
Phase 1/2 Recruiting
76 enrolled
Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
Phase 1 Completed
9 enrolled
SCALOP-2
Phase 1/2 Completed
159 enrolled
Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer
Phase 1 Completed
46 enrolled
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer
Phase 2 Completed
11 enrolled 12 charts
Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
18 enrolled 9 charts
Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma
Phase 1/2 Terminated
33 enrolled
Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
7 enrolled 8 charts
A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia
Phase 2 Withdrawn
Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Phase 1/2 Completed
55 enrolled 11 charts
A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)
Phase 1 Completed
6 enrolled
Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck
Phase 2 Completed
15 enrolled 3 charts
Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma
Phase 2 Completed
34 enrolled
Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer
Phase 1 Completed
18 enrolled
Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
Phase 1 Terminated
15 enrolled
A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
Phase 1 Completed
31 enrolled
Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer
Phase 1 Terminated
7 enrolled
Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Withdrawn
Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer
Phase 2 Terminated
1 enrolled 3 charts
Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer
Phase 1 Completed
8 enrolled
Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
Phase 1 Completed
6 enrolled
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
Phase 1/2 Terminated
29 enrolled 7 charts
Nelfinavir
Phase 1/2 Completed
15 enrolled
I-NET
Phase 1 Completed
18 enrolled